医学
类风湿性关节炎
安慰剂
痹症科
内科学
临床终点
关节炎
C反应蛋白
临床试验
随机对照试验
免疫学
病理
炎症
替代医学
作者
Jay Tuttle,Edit Drescher,Jesus Abraham Simón Campos,Paul Emery,Maria Greenwald,Alan Kivitz,H Y Rha,Pia P. Yachi,Christina Kiley,Ajay Nirula
标识
DOI:10.1056/nejmoa2209856
摘要
Peresolimab showed efficacy in a phase 2a trial in patients with rheumatoid arthritis. These results provide evidence that stimulation of the PD-1 receptor has potential efficacy in the treatment of rheumatoid arthritis. (Funded by Eli Lilly; ClinicalTrials.gov number, NCT04634253.).
科研通智能强力驱动
Strongly Powered by AbleSci AI